首页> 外文期刊>American Journal of Pathology: Official Publication of the American Association of Pathologists >Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in nonimmune-suppressed diabetic rats.
【24h】

Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in nonimmune-suppressed diabetic rats.

机译:在非免疫抑制的糖尿病大鼠中,猪胰原基移植后,来自郎格罕氏猪胰岛的细胞移植和葡萄糖耐量正常化。

获取原文
获取原文并翻译 | 示例
           

摘要

Transplantation therapy for human diabetes is limited by the toxicity of immunosuppressive drugs. However, even if toxicity can be minimalized, there will still be a shortage of human donor organs. Xenotransplantation of porcine islets may be a strategy to overcome these supply problems. Xenotransplantation in mesentery of pig pancreatic primordia obtained very early during organogenesis [embryonic day 28 (E28)] can obviate the need for immune suppression in rats or rhesus macaques. Here, in rats transplanted previously with E28 pig pancreatic primordia in the mesentery, we show normalization of glucose tolerance in nonimmune-suppressed streptozotocin-diabetic LEW rats and insulin and porcine proinsulin mRNA-expressing cell engraftment in the kidney following implantation of porcine islets beneath the renal capsule. Donor cell engraftment was confirmed using fluorescent in situ hybridization for the porcine X chromosome and electron microscopy. In contrast, cells from islets did not engraft in the kidney without prior transplantation of E28 pig pancreatic primordia in the mesentery. This is the first report of prolonged engraftment and sustained normalization of glucose tolerance following transplantation of porcine islets in nonimmune-suppressed, immune-competent rodents. The data are consistent with tolerance induction to a cell component of porcine islets induced by previous transplantation of E28 pig pancreatic primordia.
机译:人类糖尿病的移植治疗受到免疫抑制药物毒性的限制。然而,即使毒性可以最小化,人类供体器官仍将短缺。猪胰岛的异种移植可能是克服这些供应问题的一种策略。在器官发生过程中很早[胚胎第28天(E28)]获得的猪胰腺原基肠系膜异种移植可以消除对大鼠或恒河猴的免疫抑制的需要。在这里,在先前在肠系膜中移植了E28猪胰腺原基的大鼠中,我们显示了非免疫抑制的链脲佐菌素-糖尿病的LEW大鼠以及胰岛素和猪胰岛素原mRNA表达的细胞在肾脏中的胰岛植入后肾脏中葡萄糖耐量的正常化肾囊。使用荧光原位杂交技术对猪X染色体和电子显微镜证实了供体细胞的植入。相反,如果未事先在肠系膜中移植E28猪胰腺原基,则来自胰岛的细胞不会植入肾脏。这是猪胰岛在非免疫抑制的,有免疫能力的啮齿类动物中移植后,长期移植和葡萄糖耐量持续正常化的首次报道。该数据与先前对E28猪胰腺原基的移植诱导的对猪胰岛细胞成分的耐受诱导一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号